BMY Bristol-Myers Squibb Company

-

Bristol-Myers Squibb Beat Expectations, Raises Guidance

Thursday, July 30, 2026 · 6:59 AM ET

Bristol-Myers Squibb (BMY) reported earnings of $2.04 per share on revenue of $12.97 billion for the second quarter ended June 2026. The consensus earnings estimate was $1.59 per share on revenue of $11.67 billion. The Earnings Whisper number was $1.70 per share. The company beat expectations by 20.00% while revenue grew 5.74% on a year-over-year basis.

The company said it expects 2026 earnings of $6.75 to $7.00 per share on revenue of $49.0 billion to $50.0 billion. The company's previous guidance was earnings of $6.05 to $6.35 per share on revenue of $46.0 billion to $47.5 billion, and the current consensus earnings estimate is $6.34 per share on revenue of $47.48 billion for the year ending December 31, 2026.

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
$2.04
Earnings Whisper®
$1.70
Consensus Estimate
$1.59
Earnings Surprise
Earnings Growth39.7 %
Reported Revenue
$12.97B
Revenue Estimate
$11.67B
Revenue Surprise
Revenue Growth5.7 %

Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

Thursday, July 30, 2026 · 6:59 AM ET Business Wire

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today reported second quarter 2026 financial results.

Visit the company’s Investor Relations website at http://investor.bms.com to view the detailed second quarter 2026 earnings press release and investor presentation.

The company will host a conference call and live audio webcast for analysts and investors at 8:15 a.m. ET today, July 30, 2026, which is accessible here. Company executives will review financial results with the investment community during the call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

For more information, contact:
Media Relations: media@bms.com
Investor Relations: investor.relations@bms.com

Source: Bristol Myers Squibb